Business
Investor results presentation
Investor results presentation.
About this update from Inspiration Healthcare Group Plc
[{"type":"text","content":"\n\nInspiration Healthcare Group plc\n(\"Inspiration Healthcare\", the \"Company\" or the \"Group\")\n \nInvestor results presentation\n \nInspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in class, specialist neonatal intensive care medical devices, announces that the Company will provide a live presentation to investors via the Investor Meet Company platform on Friday, 6 October 2023 at 11am BST.\n \nThe presentation will give an update on the Company and an overview of the Group's interim results for the six months ended 31 July 2023 which will be issued on Tuesday, 3 October 2023, as stated in the recent trading update. \n \nThe presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet Inspiration Healthcare.\nTo register for the presentation, please use this link:\nhttps://www.investormeetcompany.com/inspiration-healthcare-group-plc/register-investor\n \nInvestors who already follow Inspiration Healthcare on the Investor Meet Company platform will automatically be invited.\n \nFor further information, please contact:\n \n\n\n\nInspiration Healthcare Group plc\n\n\nTel: +44 (0)330 175 0000\n \n\n\n\n\nNeil Campbell, Chief Executive Officer\n\n\n\n\n\n\n\nAlan Olby, Chief Financial Officer\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\nWalbrook PR Ltd (Media and Investor Relations)\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nAnna Dunphy\n\n\nMob: +44 (0) 7876 741 001\n\n\n\n\nStephanie Cuthbert\n\n\nMob: +44 (0) 7796 794 663\n\n\n\n\nLouis Ashe-Jepson\n\n\nMob: +44 (0) 7747 515 393\n\n\n\n\n\n\n\n\n \n \nAbout Inspiration Healthcare\n \nInspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.\n \nThe Company has key own brand products ...